NEW YORK/LONDON (Reuters) - Merck & Co Inc is looking to sell a big portfolio of mature drugs that could fetch more than $15 billion, according to people familiar with the matter, as the U.S. drugmaker continues to streamline businesses to focus on high-growth areas. Merck, which is also in the process of selling its $14 billion consumer healthcare unit, is working with an investment bank on the potential sale of the off-patent drugs, which could draw interest from generic drugmakers, the people said. Sanofi SA , being advised by Evercore Partners Inc , is also in the market with its aging drug portfolio, which could fetch between $7 billion and $8 billion, Reuters reported on Tuesday.
via Health News Headlines - Yahoo News
Read More Here..
No comments:
Post a Comment